Pronase independent flow cytometry crossmatching of rituximab treated patients.
Sign Up to like & getrecommendations! Published in 2018 at "Human immunology"
DOI: 10.1016/j.humimm.2017.11.006
Abstract: ABO-incompatible (ABOi) kidney transplantation has become an established strategy to increase the number of available living donors. At our center, the conditioning protocol for ABOi patients is based on anti-A/B antibody removal and depletion of… read more here.
Keywords: rituximab; rit; pronase; anti rit ... See more keywords